Starting at 48-minutes into this video, Rick Perry and Bryan Hubbard address attendees at the 2025 ALEC National Policy Summit about the growing interest in ibogaine research. Their remarks focus on the potential for new clinical studies examining the compound’s possible role in treating addiction, trauma, and related neurological conditions.
The speeches also highlight ongoing legislative and policy efforts to expand research initiatives, including state-level partnerships and funding proposals. Perry and Hubbard discuss how policymakers, researchers, and advocates are working to advance scientific evaluation of ibogaine as part of broader efforts to address addiction and mental health challenges.